James L. Rogers

Array ( [id] => 9060113 [patent_doc_number] => 08546548 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-01 [patent_title] => 'Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use' [patent_app_type] => utility [patent_app_number] => 12/789345 [patent_app_country] => US [patent_app_date] => 2010-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 22956 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 289 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12789345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6267800 [patent_doc_number] => 20100298418 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'Assay for measuring plasma FGL-2 and methods and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/784006 [patent_app_country] => US [patent_app_date] => 2010-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12878 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298418.pdf [firstpage_image] =>[orig_patent_app_number] => 12784006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6581763 [patent_doc_number] => 20100291106 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING COMPLEMENT PROTEIN C3B' [patent_app_type] => utility [patent_app_number] => 12/773246 [patent_app_country] => US [patent_app_date] => 2010-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 50537 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291106.pdf [firstpage_image] =>[orig_patent_app_number] => 12773246 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11237504 [patent_doc_number] => 09464138 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-10-11 [patent_title] => 'Method for the production of domain antibodies' [patent_app_type] => utility [patent_app_number] => 13/266503 [patent_app_country] => US [patent_app_date] => 2010-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 27987 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13266503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8483247 [patent_doc_number] => 20120282654 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-08 [patent_title] => 'ANTIBODY PURIFICATION' [patent_app_type] => utility [patent_app_number] => 13/266860 [patent_app_country] => US [patent_app_date] => 2010-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12020 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13266860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8909630 [patent_doc_number] => 08481694 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-09 [patent_title] => 'Purification of immunoconjugates' [patent_app_type] => utility [patent_app_number] => 12/769460 [patent_app_country] => US [patent_app_date] => 2010-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 7390 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12769460 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007085 [patent_doc_number] => 20110059116 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'LASER-BASED VACCINE ADJUVANTS' [patent_app_type] => utility [patent_app_number] => 12/754081 [patent_app_country] => US [patent_app_date] => 2010-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18091 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059116.pdf [firstpage_image] =>[orig_patent_app_number] => 12754081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6038911 [patent_doc_number] => 20110091960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'Compositions and Methods for Detection of Antibody Binding to Cells' [patent_app_type] => utility [patent_app_number] => 12/732979 [patent_app_country] => US [patent_app_date] => 2010-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 28715 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20110091960.pdf [firstpage_image] =>[orig_patent_app_number] => 12732979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8056461 [patent_doc_number] => 20120077963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'METHOD FOR REMOVING VIRUSES FROM HIGH CONCENTRATION MONOCLONAL ANTIBODY SOLUTION' [patent_app_type] => utility [patent_app_number] => 13/260419 [patent_app_country] => US [patent_app_date] => 2010-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8515 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20120077963.pdf [firstpage_image] =>[orig_patent_app_number] => 13260419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6294566 [patent_doc_number] => 20100240054 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'IDENTIFICATION AND ISOLATION OF FETAL CELLS AND NUCLEIC ACID' [patent_app_type] => utility [patent_app_number] => 12/725331 [patent_app_country] => US [patent_app_date] => 2010-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5442 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20100240054.pdf [firstpage_image] =>[orig_patent_app_number] => 12725331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8146274 [patent_doc_number] => 08163281 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-24 [patent_title] => 'Treatment of drug-related side effect and tissue damage by targeting the CD24-HMGB1-Siglec10 axis' [patent_app_type] => utility [patent_app_number] => 12/716842 [patent_app_country] => US [patent_app_date] => 2010-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 15280 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/163/08163281.pdf [firstpage_image] =>[orig_patent_app_number] => 12716842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7777266 [patent_doc_number] => 20120040377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'RECOGNITION OF CYP2E1 EPITOPES' [patent_app_type] => utility [patent_app_number] => 13/203402 [patent_app_country] => US [patent_app_date] => 2010-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7147 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20120040377.pdf [firstpage_image] =>[orig_patent_app_number] => 13203402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7652061 [patent_doc_number] => 20110301330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'CELLULOSE GEL FOR PURIFICATION OF IMMUNOGLOBULIN' [patent_app_type] => utility [patent_app_number] => 13/201647 [patent_app_country] => US [patent_app_date] => 2010-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13076 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0301/20110301330.pdf [firstpage_image] =>[orig_patent_app_number] => 13201647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6519334 [patent_doc_number] => 20100203062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'Methods and Compositions for Treatment of Neovascularization' [patent_app_type] => utility [patent_app_number] => 12/701289 [patent_app_country] => US [patent_app_date] => 2010-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 16710 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20100203062.pdf [firstpage_image] =>[orig_patent_app_number] => 12701289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9749397 [patent_doc_number] => 08840868 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-23 [patent_title] => 'Non-invasive detection of complement-mediated inflammation using CR2-targeted nanoparticles' [patent_app_type] => utility [patent_app_number] => 13/148028 [patent_app_country] => US [patent_app_date] => 2010-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 52426 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13148028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8675664 [patent_doc_number] => 08383778 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-26 [patent_title] => 'IL-1 binding proteins' [patent_app_type] => utility [patent_app_number] => 12/696314 [patent_app_country] => US [patent_app_date] => 2010-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32995 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12696314 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10109202 [patent_doc_number] => 09144594 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-29 [patent_title] => 'Cathepsin L mediated diseases and associated methods and products' [patent_app_type] => utility [patent_app_number] => 12/693523 [patent_app_country] => US [patent_app_date] => 2010-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 155 [patent_no_of_words] => 38030 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12693523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9944043 [patent_doc_number] => 08993343 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-31 [patent_title] => 'CD93 or use of soluble fragment thereof' [patent_app_type] => utility [patent_app_number] => 13/146876 [patent_app_country] => US [patent_app_date] => 2010-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 11850 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13146876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7744854 [patent_doc_number] => 20120022239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'PRECIPITATION OF BIOMOLECULES WITH NEGATIVELY CHARGED POLYMERS' [patent_app_type] => utility [patent_app_number] => 13/144100 [patent_app_country] => US [patent_app_date] => 2010-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11774 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20120022239.pdf [firstpage_image] =>[orig_patent_app_number] => 13144100 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7721055 [patent_doc_number] => 20120010390 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'SEPARATION METHOD USING SINGLE POLYMER PHASE SYSTEMS' [patent_app_type] => utility [patent_app_number] => 13/143560 [patent_app_country] => US [patent_app_date] => 2010-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 20087 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20120010390.pdf [firstpage_image] =>[orig_patent_app_number] => 13143560 [rel_patent_id] =>[rel_patent_doc_number] =>)